Christina Fournier

Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis

Sabrina Paganoni, Eric A. Macklin, Suzanne Hendrix et al. · New England Journal of Medicine · 2020 · 505 citations · Full text

Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i> -associated amyotrophic lateral sclerosis

Tania F. Gendron, Jeannie Chew, Jeannette N. Stankowski et al. · Science Translational Medicine · 2017 · 266 citations · Full text

Long‐term survival of participants in the <scp>CENTAUR</scp> trial of sodium phenylbutyrate‐taurursodiol in <scp>amyotrophic lateral sclerosis</scp>

Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson et al. · Muscle & Nerve · 2020 · 174 citations · Full text

Randomized phase 2 trial of NP001, a novel immune regulator

Robert G. Miller, Gilbert Block, Jonathan Katz et al. · Neurology Neuroimmunology & Neuroinflammation · 2015 · 94 citations · Full text

Predicting disease progression in amyotrophic lateral sclerosis

Albert A. Taylor, Christina Fournier, Meraida Polak et al. · Annals of Clinical and Translational Neurology · 2016 · 77 citations · Full text